Characteristics of study participants
| Participant number (sex) | Age | Genetic classification | Height | Height SDS | Childhood GH treatment |
| P01 (male) | 31–40 | 11p15LOM | 153.23 | −3.66 | Yes |
| P02 (male) | 31–40 | 11p15LOM | 171.25 | −1.02 | No |
| P03 (male) | 31–40 | 11p15LOM | 150.3 | −4.09 | Yes |
| P04 (male) | 31–40 | 11p15LOM | 156.85 | −3.13 | No |
| P05 (male) | 21–30 | 11p15LOM | 171.95 | −0.92 | Yes |
| P06 (male) | 31–40 | 11p15LOM | 171.9 | −0.92 | Yes |
| P07 (male) | 31–40 | 11p15LOM | 168.05 | −1.49 | Yes |
| P08 (male) | 31–40 | 11p15LOM | 146.07 | −4.71 | Yes |
| P09 (male) | 61–70 | 11p15LOM | 153.9 | −3.56 | No |
| P10 (female) | 31–40 | 11p15LOM | 149.53 | −2.37 | No |
| P11 (female) | 21–30 | Upd(7)mat | 160.87 | −0.49 | Yes |
| P12 (female) | 31–40 | 11p15LOM | 130.57 | −5.52 | No |
| P13 (female) | 21–30 | 11p15LOM | 147.7 | −2.67 | Yes |
| P14 (female) | 41–50 | 11p15LOM | 143.45 | −3.38 | No |
| P15 (female) | 51–60 | 11p15LOM | 150.1 | −2.28 | Yes |
GH, growth hormone; SDS, SD score.